UBS initiates Bill.com stock coverage with buy rating on growth outlook
UBS initiated coverage on Bill.com (BILL) with a buy rating and $64 price target, citing growth outlook and undervaluation. The stock trades at $53.74, with InvestingPro data suggesting a fair value of $77.94. UBS expects 20% upside driven by earnings growth and share buybacks. Bill.com reported mixed Q1 2027 results, beating earnings but missing revenue expectations.
How this was made
The 30-second read
Why it matters
The new buy rating and $64 target suggest a near-term upside of ~19%, likely prompting short-term buying.
Market read
Analyst upgrade provides fresh actionable insight for traders targeting fintech stocks.
What to watch
Potential macro slowdown could curb SMB spending, affecting Bill.com's growth.
Background
UBS coverage follows Bill.com's Q1 FY2027 results, which showed earnings beat but revenue miss.
Ticker impact
UBS initiated coverage on Bill.com with a buy rating and a $64 price target, citing Q1 earnings beat and growth outlook.
upward pressure as the market prices in the new target and buy rating
UBS is a respected broker; its buy rating and 19% upside target are new information that can prompt immediate trades.
Market effects
Positive outlook may lift other B2B payments and SaaS peers.
US fintech sector may see modest gains.
Limited to US-listed fintech stocks.
Counterpoint
If revenue miss signals deeper demand weakness, the target may be overly optimistic.
Key entities
- companyBill.com Holdings Inc.
US-listed B2B payments and software provider.
- analystUBS
Investment bank initiating coverage with a buy rating.



